Ocugen, Inc.

Ocugen, Inc.verified

OCGN

Price:

$0.9074

Market Cap:

$264.34M

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics In...[Read more]

Industry

Biotechnology

IPO Date

2014-12-03

Stock Exchange

NASDAQ

Ticker

OCGN

The Enterprise Value as of November 2024 (TTM) for Ocugen, Inc. (OCGN) is 232.43M

According to Ocugen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 232.43M. This represents a change of -19.74% compared to the average of 289.59M of the last 4 quarters.

Ocugen, Inc. (OCGN) Historical Enterprise Value (quarterly & annually)

How has OCGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Ocugen, Inc. over the last ten years is 129.39M. The current 232.43M Enterprise Value has changed 17.86% with respect to the historical average. Over the past ten years (40 quarters), OCGN's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the December 2014 quarter at -8900880.00.

Quarterly (TTM)
Annual

Average

129.39M

Median

28.15M

Minimum

-39435120.00

Maximum

795.66M

Ocugen, Inc. (OCGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ocugen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 15.37%

Maximum Annual Enterprise Value = 795.66M

Minimum Annual Increase = -639.29%

Minimum Annual Enterprise Value = -39435120.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023107.97M-48.04%
2022207.79M-73.88%
2021795.66M332.79%
2020183.84M15.37%
20191.19M-109.87%
2018-12039999.04-130.43%
201739.57M-639.29%
2016-7337476.00-143.84%
201516.74M-142.44%
2014-39435120.00-127.94%

Ocugen, Inc. (OCGN) Average Enterprise Value

How has OCGN Enterprise Value performed in the past?

The current Enterprise Value of Ocugen, Inc. (OCGN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

370.47M

5-year avg

259.29M

10-year avg

129.39M

Ocugen, Inc. (OCGN) Enterprise Value vs. Peers

How is OCGN’s Enterprise Value compared to its peers?

Ocugen, Inc.’s Enterprise Value is less than Vaxart, Inc. (0), greater than Novavax, Inc. (132.65M), less than CohBar, Inc. (1.02B), greater than Rain Therapeutics Inc. (-4477266.00), greater than Ocean Biomedical, Inc. (7.16M), greater than Elevation Oncology, Inc. (35.97M), greater than AVROBIO, Inc. (18.49M), greater than Zura Bio Limited (-85302404.00), greater than Enveric Biosciences, Inc. (-9969663.00), greater than Hepion Pharmaceuticals, Inc. (202.96K), greater than null (5.35M),

CompanyEnterprise ValueMarket cap
0$136.49M
132.65M$1.36B
1.02B$1.45M
-4477266.00$44.01M
7.16M$24.95M
35.97M$35.67M
18.49M$5.24M
-85302404.00$178.25M
-9969663.00$3.31M
202.96K$4.62M
5.35M$0

Build a custom stock screener for Ocugen, Inc. (OCGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocugen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocugen, Inc. (OCGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocugen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ocugen, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ocugen, Inc. (OCGN)?

What is the 3-year average Enterprise Value for Ocugen, Inc. (OCGN)?

What is the 5-year average Enterprise Value for Ocugen, Inc. (OCGN)?

How does the current Enterprise Value for Ocugen, Inc. (OCGN) compare to its historical average?